Intelligence · Clinical Development
Pipeline search results
Programs matching “cisplatin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 56 pipeline programs matching "cisplatin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
2020HXFH037
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
CISPLATIN
Ningbo Cancer Hospital
Ovarian epithelial cancer : intraperitoneal resectable relapse
1 trial -
CISPLATIN, CARBOPLATIN
Cardiff Oncology
Human papillomavirus (HPV)-positive oropharyngeal cancer
1 trial -
Cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Cisplatin
BRIGHT MINDS BIOSCIENCES INC.
Squamous Cell Carcinoma of Head and Neck
1 trial -
Cisplatin
Children's Hospital of Fudan University
Localized Osteosarcoma
1 trial -
Cisplatin /ml Concentrate for Advanced head and neck cancer
Ningbo Cancer Hospital
Advanced head and neck cancer
1 trial -
DLY201619
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-small Cell Lung Cancer Stage IIIA
1 trial -
Docetaxel, cisplatin and fluorouracil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Gemcitabine,Cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Paclitaxel or docetaxel + Cisplatin or carboplatin
The First People's Hospital of Lianyungang
Uterine Cervical Neoplasms
1 trial -
Paclitaxel, Cisplatin Plus 5-FU (TCF)
The First People's Hospital of Lianyungang
Esophageal Cancer Stage IIB
1 trial -
cetuximab + cisplatin + vinorelbine
Merck KGaA, Darmstadt, Germany
Non Small Cell Lung Cancer (NSCLC)
1 trial -
cisplatin
Pari Pharma GmbH
Lung Cancer
1 trial -
cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cavity
1 trial -
cisplatin
United Therapeutics Europe Ltd
Bladder Cancer
1 trial -
cisplatin i.p.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epithelial Carcinoma, Ovarian
1 trial -
gemcitabine and cisplatin (Induction chemotherapy)
Sun Yat-sen University
Nasopharyngeal Carcinoma
1 trial -
gemcitabine and cisplatin (Induction chemotherapy)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
12.5mg sunitinib with Cisplatin and Gemcitabine
Hospital Authority, Hong Kong
Nasopharyngeal Carcinoma
1 trial -
2020-S112
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uterine Cervical Neoplasm
1 trial -
Adebrelimab+Albumin paclitaxel +Cisplatin
The First People's Hospital of Lianyungang
Locally Advanced Hypopharyngeal Cancer
1 trial -
Arazasetron besylate
Orion Laboratories Pty.
Cisplatine induced hearing loss
1 trial -
BLEOMYCIN, CISPLATIN
Fondazione Telethon ETS
patients with newly diagnosed or recurrent high-grade or initially invasive precancerous squamous lesions of the vulva and non-invasive vulvar Paget's disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.